Initial experience of treating prostate cancer patients with coronary artery disease through robot-assisted radical Prostatectomy

Shuai JIANG,Jianming GUO,Li'an SUN,Ruiyi WU,Jianping ZHANG,Li LIU,Hang WANG,Yanjun ZHU,Zhibing XU
DOI: https://doi.org/10.13201/j.issn.1001-1420.2017.08.006
2017-01-01
Journal of Clinical Urology
Abstract:Objective:To explore the safety and efficiency of Da Vinci robot treating prostate cancer patients with coronary artery disease.Method:We retrospectively analyzed the perioperative data of prostate cancer patients with coronary artery disease from Jul.2012 to Feb.2017 in our department.Result:Thirty-one patients with prostate cancer and coronary artery disease were included in the study.Their average age was 68 (range,58-78) years old.Total PSA before surgery was 17.0 (range,1.81-66.0) ng/ml.All of the surgeries were successful.The withdrawal period of anticoagulant drug before surgery was 8.8 (range,6 21) days.The set up time of Da Vinci robot system was 21 (range,13-40) min.The average operation time was 139 (range,90-230) min.The amount of blood loss during surgery was 161 (range,20-450) ml.No surgery converted to open.No postoperative complication was observed.The mean hospital stay was 12 (range,7-25) days.The mean catheter retention duration was 15 (range.7-23) days.The mean PSA level six weeks after surgery was 0.07 (range,0-0.5) ng/ml.Conclusion:The Da Vinci robot system is effect and safe in the patients with prostate cancer and coronary artery disease.
What problem does this paper attempt to address?